Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.23856 | 69 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.23789 | 69 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.2041 | 68 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.21732 | 68 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.22278 | 69 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.24684 | 69 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.23432 | 68 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.22729 | 69 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.21781 | 68 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.23457 | 69 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.22585 | 69 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.22943 | 69 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.23648 | 69 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.23002 | 69 |